NCT01019473 - Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2011

Conditions

Huntington's DiseaseChorea

Interventions

DRUG

AFQ056

DRUG

Placebo

Trial Locations (10)

Novartis Investigator Site, Berlin

Novartis Investigator Site, Bochum

Novartis Investigator Site, Münster

Novartis Investigator Site, Taufkirchen

Novartis Investigator Site, Tübingen

Novartis Investigator Site, Ulm

Novartis Investigator Site, Birmingham

Novartis Investigator Site, Cardiff

Novartis Investigator Site, Manchester

Novartis Investigator Site, Oxford